Home LiteratureArticle Details
PMID: 4332044 Published · ppublish English Journal Article

Susceptibility of recent isolates of Pseudomonas aeruginosa to gentamicin, polymyxin, and five penicillins, with observations on the pyocin and immunotypes of the strains.

Applied microbiology ·Vol. 22 ·No. 5 ·1971-11-00 ·Pages 870-5

Adler JL, Finland M

Abstract

The susceptibilities of recently isolated strains of Pseudomonas aeruginosa to gentamicin, polymyxin B, carbenicillin, ampicillin, penicillin G, and two newer penicillins were tested with the inocula-replicating technique by using undiluted and 10(-3) dilutions of the cultures. With either inoculum, polymyxin B was the most active agent, and a comparison with previous data from this laboratory showed that the susceptibility of P. aeruginosa to this antibiotic had not changed over the past 20 years. Gentamicin was nearly as active as polymyxin, all but 2 of the 141 strains tested with the diluted inoculum being inhibited by 6.25 mug/ml or less. AB-2288, an agent resembling carbenicillin, was four times more active than carbenicillin or BLP-1654; the last two were equally active against the 10(-3) inoculum. A more marked inoculum effect was noted with the penicillin analogues tested, the increase in minimum inhibiting concentration with the undiluted culture being eight-fold for carbenicillin and at least 16-fold for AB-2288 and BLP-1654. Pyocin typing and serotyping failed to demonstrate any clearly predominating types.

MeSH Terms
Ampicillin/pharmacology Bacteriocins/analysis Carbenicillin/pharmacology Gentamicins/pharmacology Humans Microbial Sensitivity Tests Penicillin G/pharmacology Penicillin Resistance Penicillins/pharmacology Polymyxins/pharmacology Pseudomonas Infections/microbiology Pseudomonas aeruginosa/classification,drug effects,isolation & purification,metabolism Serotyping
Chemicals
Bacteriocins Gentamicins Penicillins Polymyxins Ampicillin Carbenicillin Penicillin G
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Adler J L
Finland M
References (23)
23 references, click to expand
  1. Observations on bacteriophage typing of Pseudomonas aeruginosa.
    J Clin Invest. 1961 Nov;40:2064-75 PMID: 14488221
  2. Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.
    Am J Med Sci. 1968 Mar;255:179-95 PMID: 4384524
  3. Susceptibility and crossresistance of bacteria to four related antibiotics: kanamycin, paromomycin, neomycin and streptomycin.
    Proc Soc Exp Biol Med. 1958 Nov;99(2):312-6 PMID: 13601854
  4. Use of gentamicin in combinations with other antibiotics.
    J Infect Dis. 1969 Apr-May;119(4):370-7 PMID: 4306973
  5. Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea.
    Biochem J. 1965 Sep;96(3):739-52 PMID: 5862414
  6. Further studies in the pyocine typing of Pseudomonas pyocyanea.
    J Med Microbiol. 1969 Feb;2(1):17-25 PMID: 4980696
  7. New immunotype schema for Pseudomonas aeruginosa based on protective antigens.
    J Bacteriol. 1969 May;98(2):835-6 PMID: 4977486
  8. Carbenicillin: activity in vitro and absorption and excretion in normal young men.
    Appl Microbiol. 1968 Nov;16(11):1753-60 PMID: 4387223
  9. Occurrence of serious bacterial infections since introduction of antibacterial agents.
    J Am Med Assoc. 1959 Aug 29;170:2188-97 PMID: 13822924
  10. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy.
    Ann Intern Med. 1970 Jun;72(6):857-68 PMID: 5448745
  11. Susceptibility of Pseudomonas to ten antibiotics in vitro: some properties of recently isolated strains.
    Am J Clin Pathol. 1954 Oct;24(10):1121-32 PMID: 13207039
  12. SYNERGISTIC ACTION OF PENICILLINS AND CEPHALOSPORINS AGAINST PSEUDOMONAS PYOCYANEA.
    Nature. 1964 Dec 12;204:1066-9 PMID: 14243384
  13. Synergistic penicillin combinations for treatment of human urinary-tract infections.
    Antimicrob Agents Chemother (Bethesda). 1966;6:149-55 PMID: 4964451
  14. POLYMYXIN B AND COLISTIN: IN VITRO ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA.
    Am J Med Sci. 1965 Feb;249:172-4 PMID: 14257308
  15. Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients.
    Ann N Y Acad Sci. 1967 Sep 27;145(2):224-36 PMID: 4327436
  16. Infection and antibiotic usage at Boston City Hospital, January 1970.
    Arch Intern Med. 1971 Mar;127(3):460-5 PMID: 5544315
  17. Pseudomonas aeruginosa epidemic traced to delivery-room resuscitators.
    N Engl J Med. 1967 May 4;276(18):991-6 PMID: 4960579
  18. In vitro susceptibility of recently isolated strains of Pseudomonas aeruginosa to ten antibiotics.
    Am J Med Sci. 1961 Nov;242:551-9 PMID: 14488220
  19. Typing of Pseudomonas pyocyanea by pyocine production.
    J Pathol Bacteriol. 1966 Apr;91(2):339-45 PMID: 4958434
  20. Isolation and characterization of antigenic components of a new heptavalent Pseudomonas vaccine.
    Nat New Biol. 1971 Feb 17;229(7):209-10 PMID: 5281014
  21. GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS.
    Am J Med Sci. 1964 Nov;248:528-44 PMID: 14224772
  22. Chemical, biological and clinical observations on colistin.
    Antibiot Annu. 1959-1960;7:61-74 PMID: 13846121
  23. In vitro sensitivity of Bacillus proteus and Pseudomonas aeruginosa to seven antibiotics; penicillin, streptomycin, bacitracin, polymyxin, aerosporin, aureomycin, and chloromycetin.
    J Lab Clin Med. 1950 Feb;35(2):205-14 PMID: 15404235
Article Info
Journal
Applied microbiology
Abbr.
Appl Microbiol
ISSN
0003-6919
Published
1971-11-00
Pages
870-5
Language
English
Region
United States
NLM ID
7605802
PMCID
PMC376437
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]